J&J plans to spin out orthopedics business
CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such as cardiovascular and robotics.
Uncategorized
No Trump Drug Pricing Plan For J&J—Yet
Reporting third quarter earnings on Tuesday, Johnson & Johnson CEO Joaquin Duato said the healthcare giant has not yet secured a drug pricing deal with the White House, but discussions are ongoing.
31,000 Kaiser Permanente workers begin strike in Northern California, Hawaii
The union that represents the workers says the five-day strike is the largest in its history.
31,000 Kaiser Permanente workers begin strike in Northern California, Hawaii Read More »
Top Democrat questions Medicare Advantage insurers on AI claims denials
The letter from Sen. Richard Blumenthal comes one year after a Senate investigation criticized major MA payers for using predictive technology to deny post-acute care.
Top Democrat questions Medicare Advantage insurers on AI claims denials Read More »
Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says
Slapped with the most severe post-inspection classification, the state of Novo Nordisk’s Indiana manufacturing site could pose a problem for clients, including Regeneron and Scholar Rock.
Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says Read More »
Thanks to Pfizer, Drug Pricing Clouds Begin To Clear as Q3 Earnings Roll Out
J&J reports today, just two weeks after Pfizer secured certainty on tariffs and drug pricing. Analysts expect to hear about plans from the rest of the industry during third period earnings calls.
Thanks to Pfizer, Drug Pricing Clouds Begin To Clear as Q3 Earnings Roll Out Read More »
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such biomarker-based tests could “remove some of the bottlenecks” in uptake.
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use Read More »
Kailera Banks Massive $600M Raise For Phase III Obesity Study
Kailera’s lead asset, KAI-9531, elicited an average weight loss of more than 17% in a Phase III study in China. The biotech expects to launch a global late-stage program for the drug this year.
Kailera Banks Massive $600M Raise For Phase III Obesity Study Read More »
Un modo de reforzar un tratamiento contra un cáncer de la piel
Unos científicos han identificado una estrategia para aumentar la eficacia de un tratamiento no invasivo contra un tipo común de cáncer de la piel. Una investigación del Centro de Biología Molecular Severo Ochoa (CBM, un centro mixto del Consejo Superior d …
Un modo de reforzar un tratamiento contra un cáncer de la piel Read More »
Descifran un receptor cerebral clave en la epilepsia y la esquizofrenia
Un equipo internacional de científicos ha conseguido desentrañar la estructura de un receptor cerebral, clave en enfermedades neurológicas como la epilepsia y la esquizofrenia. Este equipo lo ha liderado el Laboratorio de Biología Molecular (LMB) del Consejo de I …
Descifran un receptor cerebral clave en la epilepsia y la esquizofrenia Read More »